ANRO4:03 PMAlto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlightsaltoneuroscience.com
ANRO7:47 AMAlto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stockaltoneuroscience.com
ANRO8:03 AMAlto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedoniaaltoneuroscience.com